Alibaba Health Information Technology Ltd
HKEX:241
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.62
6.15
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Alibaba Health Information Technology Ltd stock under the Base Case scenario is 2.75 HKD. Compared to the current market price of 4.12 HKD, Alibaba Health Information Technology Ltd is Overvalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Alibaba Health Information Technology Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Alibaba Health Information Technology Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Alibaba Health Information Technology Ltd. is a key player in the rapidly evolving landscape of digital healthcare in China, one of the world's largest markets for health services. This innovative subsidiary of Alibaba Group was founded in 2014, aiming to harness the power of advanced technology to enhance healthcare accessibility and efficiency. By leveraging big data, artificial intelligence, and cloud computing, Alibaba Health develops a comprehensive ecosystem that connects patients and healthcare providers seamlessly. Their platforms enable users to book appointments, purchase medications online, and access personalized health information, thereby improving overall health management for...
Alibaba Health Information Technology Ltd. is a key player in the rapidly evolving landscape of digital healthcare in China, one of the world's largest markets for health services. This innovative subsidiary of Alibaba Group was founded in 2014, aiming to harness the power of advanced technology to enhance healthcare accessibility and efficiency. By leveraging big data, artificial intelligence, and cloud computing, Alibaba Health develops a comprehensive ecosystem that connects patients and healthcare providers seamlessly. Their platforms enable users to book appointments, purchase medications online, and access personalized health information, thereby improving overall health management for millions of individuals across China.
As an investor, one cannot overlook Alibaba Health's strategic position in the booming digital healthcare sector fueled by an aging population and rising health awareness among Chinese consumers. The company has established significant partnerships with hospitals, pharmacies, and other healthcare stakeholders, facilitating integration across the health system. With its robust technological infrastructure and the backing of the Alibaba Group, Alibaba Health is well-equipped to capitalize on emerging trends and regulatory shifts in China's healthcare environment. Their ambitious growth strategy and commitment to innovation position them as a potential long-term investment, promising not only strong financial returns but also a meaningful impact on the lives of individuals seeking quality healthcare services.
Alibaba Health Information Technology Ltd., a subsidiary of Alibaba Group, primarily operates in the healthcare sector and leverages technology to improve healthcare services in China. Its core business segments can be categorized as follows:
-
Online Pharmaceutical Sales: Alibaba Health operates an e-commerce platform for the sale of pharmaceuticals, providing a digital marketplace that connects consumers with licensed pharmacies. This segment includes the sale of prescription and over-the-counter medications through its platforms, ensuring regulatory compliance and authenticity.
-
Healthcare Services: This segment provides a broad range of healthcare services, including online consultations with medical professionals, appointment scheduling, and management of patient records. Alibaba Health aims to improve access to healthcare and streamline services through its digital platforms.
-
Health Management: Alibaba Health offers health management services, which include health assessments, disease prevention programs, and chronic disease management solutions. This segment focuses on promoting wellness and proactive healthcare through digital tools and analytics.
-
Medical Data and Cloud Solutions: The company provides medical data services, utilizing big data analytics and cloud computing to offer hospitals, clinics, and medical organizations insights into patient management and healthcare outcomes. This segment emphasizes the collection, storage, and analysis of health data to improve service delivery.
-
Healthcare Supply Chain Management: Alibaba Health supports supply chain solutions for the healthcare industry, optimizing logistics and distribution for medical products, equipment, and pharmaceuticals. This involves managing inventory and ensuring the efficient flow of goods from manufacturers to consumers.
-
Digital Platforms and Software Solutions: The company develops and licenses software solutions for healthcare providers, enhancing their operational efficiency. This includes electronic health records (EHRs), management systems, and telemedicine applications, aimed at improving clinical workflows.
Through these segments, Alibaba Health seeks to integrate technology into healthcare, improving access, reducing costs, and enhancing the quality of care in China and potentially beyond.
Alibaba Health Information Technology Ltd. has several unique competitive advantages that distinguish it from its rivals in the healthcare technology sector:
-
Integration with Alibaba Ecosystem: As part of the broader Alibaba Group, Alibaba Health benefits from synergies across various business units, including e-commerce, cloud computing, and digital payments. This integration allows for seamless access to a large customer base and enhanced operational capabilities.
-
Data Utilization and Analytics: Alibaba Health has access to extensive data collected from various health-related transactions and interactions. The ability to leverage big data analytics can enhance decision-making, improve patient care, and personalize health services, giving it an edge over competitors who may not have such enriched data.
-
Strong Brand Recognition: Alibaba is a well-established brand in China and beyond. The reputation of the Alibaba Group lends credibility and trust to Alibaba Health, which can be a significant factor in attracting users and partners in the healthcare space.
-
Robust Digital Infrastructure: Alibaba Health leverages Alibaba Cloud's advanced technology and infrastructure, allowing for scalable and secure health solutions. This technical foundation can facilitate innovation and the development of new healthcare applications and services.
-
Regulatory Collaboration: Alibaba Health has engaged with government bodies and regulatory agencies in China. This collaboration can facilitate compliance with healthcare regulations and provide insights into evolving policies that may affect the industry.
-
Focus on Telemedicine and Online Services: Alibaba Health has aggressively pursued the growth of telemedicine and online healthcare services, particularly following the COVID-19 pandemic. Its established platforms provide easy access for users and allow rapid scaling of services in response to market demand.
-
Partnerships and Collaborations: Alibaba Health has forged strategic partnerships with various healthcare organizations, pharmaceutical companies, and research institutions. These alliances can accelerate innovation, improve service offerings, and enhance overall market presence.
-
Ecosystem of Health Services: Alibaba Health provides a comprehensive suite of services, including appointment scheduling, telehealth, electronic health records, and pharmacy services. This holistic approach can attract consumers looking for integrated healthcare solutions.
-
Investment in R&D: Continuous investment in research and development helps Alibaba Health stay at the forefront of technological advancements in healthcare, improving its products and services compared to competitors who may have less focus on innovation.
By leveraging these competitive advantages, Alibaba Health is well-positioned to navigate the dynamic healthcare landscape and respond effectively to challenges posed by its rivals.
Alibaba Health Information Technology Ltd, a subsidiary of Alibaba Group focusing on health-related technology, faces several risks and challenges in the near future:
-
Regulatory Challenges: The healthcare industry is heavily regulated, and Alibaba Health must comply with various laws and regulations, which may include patient privacy and data protection laws. Changes in regulations could impact operations and profitability.
-
Market Competition: The health tech sector is becoming increasingly competitive with the entrance of both established players and startups. Alibaba Health must innovate continuously to maintain its market position.
-
Data Security and Privacy Concerns: Handling sensitive health data poses risks related to cybersecurity threats and data breaches. Any lapse in data security could harm reputation and lead to financial liabilities.
-
Public Trust and Acceptance: Gaining and maintaining consumer trust is critical. Misinformation about health products and services can lead to skepticism among users, which can impact user adoption rates.
-
Technological Advancements: Rapid changes in technology require Alibaba Health to adapt quickly. Failure to keep pace with advancements in AI, telemedicine, and other areas could result in lost market share.
-
Evolving Consumer Behavior: Changes in consumer preferences and behaviors, especially post-COVID-19, may lead to fluctuating demand for digital health services. Alibaba Health must anticipate and respond to these changes effectively.
-
Partnership Dependency: Alibaba Health relies on partnerships with healthcare providers and other stakeholders. The stability and willingness of these partners can significantly influence its business operations.
-
Global Market Dynamics: As Alibaba Health looks to expand internationally, it may face challenges related to local regulations, cultural differences, and varying healthcare systems.
-
Economic Factors: Economic downturns or shifts can impact healthcare spending. Changes in disposable income may affect consumer ability to pay for health tech services or products.
-
Reputation Management: Any negative incident, such as poor service quality or product issues, could impact the brand’s reputation and user base.
Navigating these challenges effectively will be critical for Alibaba Health's continued growth and success in the dynamic health technology landscape.
Revenue & Expenses Breakdown
Alibaba Health Information Technology Ltd
Balance Sheet Decomposition
Alibaba Health Information Technology Ltd
Current Assets | 13.5B |
Cash & Short-Term Investments | 9.6B |
Receivables | 785.1m |
Other Current Assets | 3.2B |
Non-Current Assets | 6.2B |
Long-Term Investments | 4.2B |
PP&E | 103.7m |
Intangibles | 1.1B |
Other Non-Current Assets | 780.4m |
Current Liabilities | 5B |
Accounts Payable | 3.4B |
Other Current Liabilities | 1.7B |
Non-Current Liabilities | 135.7m |
Long-Term Debt | 48m |
Other Non-Current Liabilities | 87.7m |
Earnings Waterfall
Alibaba Health Information Technology Ltd
Revenue
|
27B
CNY
|
Cost of Revenue
|
-21.1B
CNY
|
Gross Profit
|
5.9B
CNY
|
Operating Expenses
|
-5.2B
CNY
|
Operating Income
|
725.3m
CNY
|
Other Expenses
|
158.2m
CNY
|
Net Income
|
883.5m
CNY
|
Free Cash Flow Analysis
Alibaba Health Information Technology Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Alibaba Health Information Technology Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Alibaba Health Information Technology Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Alibaba Health Information Technology Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Score
Alibaba Health Information Technology Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Alibaba Health Information Technology Ltd
According to Wall Street analysts, the average 1-year price target for Alibaba Health Information Technology Ltd is 5.37 HKD with a low forecast of 3.35 HKD and a high forecast of 9.98 HKD.
Dividends
Current shareholder yield for Alibaba Health Information Technology Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Alibaba Health Information Technology Ltd. is an investment holding company, which engages in the provision of Internet technology, service tools, and platforms to offer medical and healthcare services. The company employs 1,334 full-time employees The firm is mainly involved in the development of pharmaceutical and healthcare product and service sales business, the operation of pharmaceutical e-commerce platform and consumer healthcare services platform, the development of tracking and digital health business and Internet healthcare business using technologies such as cloud computing and big data.
Contact
IPO
Employees
Officers
The intrinsic value of one Alibaba Health Information Technology Ltd stock under the Base Case scenario is 2.75 HKD.
Compared to the current market price of 4.12 HKD, Alibaba Health Information Technology Ltd is Overvalued by 33%.